Rationale for pertussis booster vaccination throughout life in Europe
F Zepp, U Heininger, J Mertsola… - The Lancet infectious …, 2011 - thelancet.com
Although the introduction of universal pertussis immunisation in infants has greatly reduced
the number of reported cases in infants and young children, disease incidence has been …
the number of reported cases in infants and young children, disease incidence has been …
Tos ferina en España. Situación epidemiológica y estrategias de prevención y control. Recomendaciones del Grupo de Trabajo de Tos ferina
M Campins, D Moreno-Pérez, A Gil-de Miguel… - … y Microbiología Clínica, 2013 - Elsevier
En los últimos años se está observando una reemergencia de la tos ferina en los países con
amplias coberturas vacunales, con la aparición de brotes importantes. Este aumento de la …
amplias coberturas vacunales, con la aparición de brotes importantes. Este aumento de la …
[HTML][HTML] Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
M Roestenberg, E Remarque, E De Jonge, R Hermsen… - PloS one, 2008 - journals.plos.org
Background Plasmodium falciparum Apical Membrane Antigen 1 (Pf AMA1) is a candidate
vaccine antigen expressed by merozoites and sporozoites. It plays a key role in red blood …
vaccine antigen expressed by merozoites and sporozoites. It plays a key role in red blood …
Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults
J Mertsola, O Van Der Meeren, Q He… - Clinical infectious …, 2010 - academic.oup.com
Background. Booster vaccination against tetanus and diphtheria at 10-year intervals is
commonly recommended. Reduced antigen content diphtheria and tetanus toxoids and …
commonly recommended. Reduced antigen content diphtheria and tetanus toxoids and …
[HTML][HTML] Immunization against pertussis in adolescents and adults
S Esposito, N Principi - Clinical Microbiology and Infection, 2016 - Elsevier
Pertussis is a highly contagious infectious disease caused by Bordetella pertussis that can
be extremely serious, particularly in young infants. For many years the efforts of health …
be extremely serious, particularly in young infants. For many years the efforts of health …
A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults
R Booy, O Van Der Meeren, SP Ng, F Celzo… - Vaccine, 2010 - Elsevier
Reduced-antigen-content diphtheria–tetanus–acellular-pertussis (dTpa) vaccines are
predominantly recommended for once-in-a-lifetime use. A second dTpa (Boostrix™ …
predominantly recommended for once-in-a-lifetime use. A second dTpa (Boostrix™ …
[PDF][PDF] The immunological basis for immunization series: module 23: influenza vaccines
World Health Organization - 2017 - apps.who.int
This module is part of the WHO series The Immunological Basis for Immunization, which was
initially developed in 1993 as a set of eight modules, comprising one module on general …
initially developed in 1993 as a set of eight modules, comprising one module on general …
Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in …
S David, PE Vermeer-de Bondt, NAT van der Maas - Vaccine, 2008 - Elsevier
BACKGROUND: In addition to the routine enhanced passive safety surveillance of the Dutch
National Vaccination Programme, RIVM (National Institute for Public Health and the …
National Vaccination Programme, RIVM (National Institute for Public Health and the …
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age
M Blatter, LR Friedland, WM Weston, P Li, B Howe - Vaccine, 2009 - Elsevier
PURPOSE: This study was conducted to assess the immunogenicity and safety of a tetanus
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …
B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
the development of safe and immunogenic acellular pertussis vaccines for booster …